Dr. Franson currently serves as Principal of Faegre Baker Daniels Consulting and was previously Chief Medical Officer for YourEncore. He is also the former Vice President of Global Regulatory Affairs/Drug Safety for Eli Lilly & Company. Prior to his work at Lilly, Dr. Franson was an Assistant Professor of Medicine (Infectious Diseases) and Hospital Epidemiologist at Medical College of Wisconsin (Milwaukee).
Dr. Franson’s professional interests include infectious diseases in the elderly (having served as former NIA/NIH RO-1 principal investigator); hospital epidemiology (device associated nosocomial infections); and antibiotic DUR. Dr. Franson served on the Xavier University of Louisiana Board of Trustees from 2002-2008; Regulatory Advisory Board–Centres for Medicines Research International from 2003-2008; Pharmaceutical Research and Manufacturers Association (past chair of Clinical Steering Committee, past chair of GMP Task Force, past chair of FDA Staff Work Group, member-Regulatory Affairs Committee and co-chair of PDUFA-3 coordination/negotiations committee); Auburn University Harrison School of Pharmacy Dean's Advisory Committee; and Drake College of Pharmacy National Advisory Committee.
Dr. Franson also served on American Association of Colleges of Pharmacy’s Pharmaceutical Education Advisory Committee and the Association of American Medical Colleges-PhRMA Clinical Trials Forum. Dr. Franson was named James Scholar–University of Illinois College of Medicine (1977-78); is a member of Rho Chi Honor Society–Drake University College of Pharmacy; earned Lilly Chairman's Ovation Award (2002); and was awarded Sagamore of the Wabash by Indiana Governor Mitchell E. Daniels Jr. for community service. He now serves as Chair of the Critical Path Institute, on the Board of Trustees at the Christian Theological Seminary, a Director for Paratek Pharmaceuticals and Cidara Therapeutics, and is Adjunct Professor of Clinical Pharmacology at Indiana University School of Medicine.